Tweet
UZBEKISTAN TO SUPPLY MEDICINES TO ARMENIA, GEORGIA
Asia Pulse
June 11, 2007 Monday 5:11 PM EST
In 2008, the Tashkent Scientific Research Institute for Vaccines and
Serums of Uzpharmsanoat state joint stock concern will deliver medicine
worth US$14 million to Armenia and Georgia, Uzbekistan Today reported.
"It is one of the first agreements on exporting the Uzbek vaccines
to foreign consumers," commented Boltaboy Kaharov, Director of the
Tashkent Scientific Research Institute for Vaccines and Serums.
"At present, we are having talks with the Afghan partners to deliver
medicine to this country."
The unique institute in Central Asia to produce vaccines and serums
and develop new medications is manufacturing medicine of two types
now: Staphylococcus vaccine and "Norma flora" (bifid bacterium and
lactose bacterium).
Soon the institute will launch production of up to 30 types of medicine
demanded domestically, as well as foreign markets.
"At present, the vaccine output is growing in Uzbekistan, and
specialists predict great number of customers", noted B. Kaharov.
However, the institute will be busy conducting research.
"We intend to cooperate actively with such young companies of the
Uzbek pharmaceutical industry as Biopharm and Noopharm, having good
conditions for vaccine production."
"We will develop cooperation with our foreign partners. We have
already reached agreement with the authorities of the Microgene
scientific industrial enterprise of the Russian Federation to set
a line of packing hydrophobia vaccines in our institute. We plan to
launch its production in Uzbekistan," he said.
Asia Pulse
June 11, 2007 Monday 5:11 PM EST
In 2008, the Tashkent Scientific Research Institute for Vaccines and
Serums of Uzpharmsanoat state joint stock concern will deliver medicine
worth US$14 million to Armenia and Georgia, Uzbekistan Today reported.
"It is one of the first agreements on exporting the Uzbek vaccines
to foreign consumers," commented Boltaboy Kaharov, Director of the
Tashkent Scientific Research Institute for Vaccines and Serums.
"At present, we are having talks with the Afghan partners to deliver
medicine to this country."
The unique institute in Central Asia to produce vaccines and serums
and develop new medications is manufacturing medicine of two types
now: Staphylococcus vaccine and "Norma flora" (bifid bacterium and
lactose bacterium).
Soon the institute will launch production of up to 30 types of medicine
demanded domestically, as well as foreign markets.
"At present, the vaccine output is growing in Uzbekistan, and
specialists predict great number of customers", noted B. Kaharov.
However, the institute will be busy conducting research.
"We intend to cooperate actively with such young companies of the
Uzbek pharmaceutical industry as Biopharm and Noopharm, having good
conditions for vaccine production."
"We will develop cooperation with our foreign partners. We have
already reached agreement with the authorities of the Microgene
scientific industrial enterprise of the Russian Federation to set
a line of packing hydrophobia vaccines in our institute. We plan to
launch its production in Uzbekistan," he said.